Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peixue Cao is active.

Publication


Featured researches published by Peixue Cao.


Bioorganic & Medicinal Chemistry | 2009

Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.

Bixue Xu; Zhengming Huang; Changxiao Liu; Zegui Cai; Weidong Pan; Peixue Cao; Xiaojiang Hao; Guangyi Liang

A series of derivatives of Matijing-Su (MTS, N-(N-benzoyl-L-phenylalanyl)-O-acetyl-L-phenylalanol) was synthesized and evaluated for their anti-hepatitis B virus (HBV) activities in 2.2.15 cells. The IC(50) of compounds 9c (1.40 microM), 9g (2.33 microM) and 9n (2.36 microM), etc. and the selective index of 9n (45.93) of the inhibition on the replication of HBV DNA were higher than those of the positive control lamivudine [41.59, (IC(50): 82.42 microM)]. Compounds 11d, 12a and 12e also exhibited significant anti-HBV activities.


Bioorganic & Medicinal Chemistry | 2011

Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.

Jingying Qiu; Bixue Xu; Zhengming Huang; Weidong Pan; Peixue Cao; Changxiao Liu; Xiao-Jiang Hao; Baoan Song; Guangyi Liang

A series of Matijing-Su (MTS, N-(N-benzoyl-l-phenylalanyl)-O-acetyl-L-phenylalanol) derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity in 2.2.15 cells. The IC(50) of compounds 14a (0.71 μM), 13c (2.85 μM), 13b (4.37 μM), etc. and the selective index of 13g (161.01), 13c (90.45), 13a (85.09) etc. of the inhibition on the replication of HBV DNA were better than those of the positive control lamivudine (IC(50): 82.42 μM, SI: 41.59). Compounds 13o, 13p, and 16a also exhibited significant anti-HBV activity.


Natural Product Research | 2009

A novel iridoid from Torricellia angulata var intermedia

Guangyi Liang; Bixue Xu; Weidong Pan; Peixue Cao; Yong Zhang; Yang Lu; Yunshan Wu; Xiao-Jiang Hao

A new iridoid, named torricellate, was isolated from root bark of Torricellia angulata var intermedia, a Chinese folk medicinal plant used to treat bone fracture, tonsillitis and asthma. Its structure was elucidated by NMR, MS, IR and UV, and confirmed by X-ray diffraction studies.


Natural Product Research | 2006

Two new naturally occurring optical polyacetylene compounds from Torricellia angulata var intermedia and the determination of their absolute configurations

Weidong Pan; Yongmin Zhang; Bixue Xu; Peixue Cao; Guangyi Liang

Four compounds were isolated from Torricellia angulata var intermedia (Harms.) Hu (Torricelliaceae), followed by formation of derivatives, which gave two new polyacetylene compounds 3 and 4 with respectively a chiral carbon center whose absolute configurations were determined unambiguously by the recently developed extended Moshers method. This is the first time to obtain natural polyacetylenes possessing a chiral hydroxyl group.


Journal of Carbohydrate Chemistry | 2014

A new ecdysteroidal glycoside from Lepidogrammitis drymoglossoides (Bak.) Ching.

Jia-Ning Yao; Zhi-Fu Li; Hua-Yong Lou; Lan Huang; Guangyi Liang; Peixue Cao; Weidong Pan

Lepidogrammitis drymoglossoides (Bak.) Ching is a medicinal plant that belongs to the family of Polypodiaceae. Previous phytochemical investigation on this genus had revealed the presence of flavonoids, sterols, and alkaloids. Here, further investigation on this medicinal plant led to the isolation of a new ecdysteroidal glycoside, ponasteroside B (1), along with a known steroidal compound, β-ecdysterone (2). The structure of 1 was determined on the basis of extensive spectroscopic analysis, including HR-MS and 1D and 2D NMR experiments, as well as a chemical hydrolysis study.


Bioorganic Chemistry | 2014

Synthesis and anti-tumor activity evaluation of Matijin-Su derivatives

Bixue Xu; Ning Wang; Weidong Pan; Jingying Qiu; Peixue Cao; Meifen Zhu; Yibin Feng; Guangyi Liang

A series of Matijin-Su (MTS, N-(N-benzoyl-l-phenylalanyl)-O-acetyl-l-phenylalanol) derivatives was synthesized and evaluated for their anti-tumor activities in hepatocellular carcinoma cells. The IC50 of compounds 1, 3, 4, 11, 13 were less than 20μM, and compound 1 and 3 showed an IC50 value of less than 9μM. Expansion inhibition could be found significantly in compound 1 and 3-treated human hepatoma cell HepG2 and PLC/PRF/5, while both compounds exhibit lower toxicity to human hepatocyte cell line L-02. Compound 1 and 3 could induce cell cycle arrest at G1/S phase. This may be attributed to increase level of intracellular reactive oxygen species (ROS). Up-regulation of p38 MAPK activity in responding the ROS stabilize p53 and activate p21 transcription, the critical regulatory in G1/S checkpoint. Observations in this study shed light on the potential of MTS derivatives compound 1 and 3 as novel suppressors to human liver cancer.


Research on Chemical Intermediates | 2016

Process development of clinical anti-HBV drug Y101: identification and synthesis of novel impurities

Zhanxing Hu; HaiJian Liao; Qiao An; Weidong Pan; Peixue Cao; Changxiao Liu; Zhengming Huang; Wen Xia; Bixue Xu; Guangyi Liang

Abstract Nine novel process impurities of N-[N-benzoyl-O-(2-dimethylaminoethyl)-l-tyrosyl]-l-phenylalaninol (Y101) observed during the laboratory optimization and later during its bulk synthesis are described in this article. The impurities were monitored by HPLC, and their structures were tentatively assigned on the basis of fragmentation patterns in LC−MS/MS and NMR spectroscopies. All of the impurities were synthesized, and their assigned constitutions were confirmed by co-injection in HPLC. In addition to the formation, synthesis, and characterization, the strategy for minimizing these impurities to a level accepted by the International Conference on Harmonisation (ICH) was also described.


Organic Process Research & Development | 2013

Identification, Synthesis, and Strategy for Minimization of Potential Impurities in the Preclinical Anti-HBV Drug Y101

Zhanxing Hu; Qiao An; Kunfeng Li; Yangong Zhang; Jingying Qiu; Bixue Xu; Weidong Pan; Peixue Cao; Changxiao Liu; Zhengming Huang; Wen Xia; Guangyi Liang


Chinese Journal of Organic Chemistry | 2014

Synthesis and Anti-hepatitis B Virus Activities of Nitric Oxide-Releasing Derivatives of Matijin-Su

Guangping Liang; Peixue Cao; Xiuxia Yang; Zhengming Huang; Qingchuan Liu; Guangyi Liang; Bixue Xu


Tetrahedron | 2014

Development of a practical and scalable synthesis of anti-HBV drug Y101

Zhanxing Hu; Yangong Zhang; Qiao An; Bixue Xu; Weidong Pan; Peixue Cao; Changxiao Liu; Zhengming Huang; Wen Xia; Jingying Qiu; Guangyi Liang

Collaboration


Dive into the Peixue Cao's collaboration.

Top Co-Authors

Avatar

Guangyi Liang

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Bixue Xu

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Weidong Pan

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Zhengming Huang

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Changxiao Liu

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zegui Cai

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Zhanxing Hu

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Xiao-Jiang Hao

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Yangong Zhang

Chinese Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge